cupric sulfide has been researched along with Experimental Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, R; Gu, Z; Lin, KT; Tan, W; Wu, Y; Xiang, H; Yan, L; Yang, D; Zhao, Y; Zhou, R | 1 |
| Cheng, J; He, D; Huang, G; Li, W; Wang, R; Zhang, Y; Zhu, J | 1 |
| Qu, J; Shen, M; Shi, X; Sun, W; Wang, Y; Xia, J; Xu, F; Zhang, C | 1 |
| Amador, E; Arshad, M; Chen, W; Chen, Z; Jin, M; Li, H; Nasir, JA; Rehman, ZU; Wang, Z | 1 |
| Cao, Q; Cui, Z; Guan, G; Hu, J; Peng, X; Qiu, H; Wan, X; Wang, S; Wang, W; Xiao, J; Zhang, W; Zhang, Y; Zou, R | 1 |
| Chen, A; Chen, W; He, Y; Wang, X; Xie, X; Xie, Z; Yao, K; Yuan, M; Zhang, R; Zhao, B; Zhong, M | 1 |
| Dong, L; Du, K; Feng, J; Gao, X; Li, K; Lu, Y; Wen, D; Zhang, H; Zhang, M | 1 |
7 other study(ies) available for cupric sulfide and Experimental Neoplasms
| Article | Year |
|---|---|
Plasmonic AuPt@CuS Heterostructure with Enhanced Synergistic Efficacy for Radiophotothermal Therapy.
Topics: Animals; Cell Line, Tumor; Copper; Female; Gold Compounds; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Photothermal Therapy; Platinum Compounds; Radiopharmaceuticals; Random Allocation | 2021 |
Construction of DOX/APC co-loaded BiOI@CuS NPs for safe and highly effective CT imaging and chemo-photothermal therapy of lung cancer.
Topics: A549 Cells; Animals; Antibiotics, Antineoplastic; Aspirin; Bismuth; Caffeine; Cell Proliferation; Cell Survival; Copper; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Particle Size; Phenacetin; Photochemotherapy; Surface Properties; Tomography, X-Ray Computed; Tumor Cells, Cultured | 2019 |
Gd-/CuS-Loaded Functional Nanogels for MR/PA Imaging-Guided Tumor-Targeted Photothermal Therapy.
Topics: Animals; Copper; Drug Delivery Systems; Gadolinium; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Mice; Nanogels; Neoplasms, Experimental; Phototherapy | 2020 |
Single source precursor synthesized CuS nanoparticles for NIR phototherapy of cancer and photodegradation of organic carcinogen.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinogens; Catalysis; Copper; Humans; Infrared Rays; MCF-7 Cells; Metal Nanoparticles; Mice, SCID; Neoplasms, Experimental; Nitrophenols; Photolysis; Phototherapy; Povidone | 2021 |
An easy-to-fabricate clearable CuS-superstructure-based multifunctional theranostic platform for efficient imaging guided chemo-photothermal therapy.
Topics: Animals; Antibiotics, Antineoplastic; Copper; Doxorubicin; Drug Delivery Systems; HeLa Cells; Humans; Male; Mice, Inbred BALB C; Nanoparticles; Neoplasms, Experimental; Photoacoustic Techniques; Photochemotherapy; Spectrophotometry, Infrared; Theranostic Nanomedicine | 2018 |
CuS-MnS
Topics: A549 Cells; Animals; Copper; Female; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Manganese Compounds; Mice; Nanoparticles; Necroptosis; Neoplasms, Experimental; Ovarian Neoplasms; Phototherapy; Sulfides | 2019 |
A highly active (102) surface-induced rapid degradation of a CuS nanotheranostic platform for in situ T
Topics: Animals; Copper; HeLa Cells; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms, Experimental; Photochemotherapy; Phototherapy; Theranostic Nanomedicine; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2019 |